Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
35.3×
Fwd P/E
24.6×
Dividend yield
1.05%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

41.40 37.64 32.36 29.14
P/S ratio
5.35 4.98 4.67 4.00
P/FCF ratio
31.36 27.53 25.68 23.88
P/Operating CF
62.68 216.55 95.75 72.04
P/B ratio
5.99 5.48 5.03 4.49
EV/Sales
5.82 5.44 5.12 4.45
EV/EBITDA
24.02 22.16 19.57 17.61
EV/FCF
34.11 30.10 28.12 26.52
Current Ratio
1.89 2.11 2.16 2.18
Net Debt/EBITDA
5.55 9.51 5.87 8.77
Debt/Equity
0.71 0.64 0.62 0.64
Earnings Yield
2.42% 2.66% 3.09% 3.43%
Free Cash Flow Yield
3.19% 3.63% 3.89% 4.19%
Free Cash Flow per Share
4.47 1.08 2.76 3.20
Book value per Share
58.66 60.01 62.55 61.37
Free Cash Flow
1,710.00 415.00 1,059.00 1,224.00
EV/EBIT
29.88 27.58 23.89 21.52
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026